Back to Feed
ClinicalTrials.gov|Clinical Trial

Objective Evaluation of Intradermal MSC-Derived Exosome Therapy on Facial Skin Quality

Mert Ersan

Abstract

This study aims to evaluate the potential effects of mesenchymal stem cell-derived suspended exosome therapy on facial skin quality using objective imaging analysis. Thirty adult participants will receive intradermal exosome applications in three treatment sessions performed at one-month intervals. Facial skin analysis will be conducted using the VISIA imaging system before each treatment session and six months after the final treatment. The study will examine changes in multiple facial skin characteristics including wrinkles, pigmentation, skin texture, pores, UV spots, red areas, brown spots, and porphyrins to determine whether exosome therapy may improve overall facial skin quality. Phase: PHASE3 Status: NOT_YET_RECRUITING Conditions: Skin Aging; Facial Aging; Skin Quality Interventions: Mesenchymal Stem Cell-Derived Exosome

Keywords

Skin AgingFacial AgingSkin Quality
Objective Evaluation of Intradermal MSC-Derived Exosome Therapy on Facial Skin Quality | StemCell Pulse | StemCell Pulse